REDWOOD CITY, Calif. — GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021. He will also join the GenapSys Board of Directors. Myers will succeed Dr. Hesaam Esfandyarpour, founder and CEO of […]
Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients SAN DIEGO — Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Society of Medical Oncology (BSMO) which is running a new national pilot to evaluate the use of comprehensive genomic […]
BALLETT Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients PierianDx, the global leader in clinical genomics knowledge, today announced a partnership with the Belgian Society of Medical Oncology (BSMO) to study the impact of comprehensive genomic profiling (CGP) on clinical […]
A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of Sales and Marketing, APAC to its global commercial team. Bruce comes to Swift with ten years of rich experience and has led efforts in increasing product adoption in his previous companies […]
— Team Promotions and Appointments Reflect Corporate Growth — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several senior management promotions and team expansion. “Twist is growing at a significant rate, meeting and exceeding […]
John C. Spinosa, M.D., Ph.D., has joined the executive management team as our Chief Medical Officer. “We are fortunate to have attracted Dr. Spinosa to join us,” stated Jay Goth, CEO. “John’s background and experience with companies large and small will be critical to our future success helping genomic sequencing companies revolutionize the healthcare, agriculture […]
BOSTON, MA and PARIS, FRANCE – Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and FounderDr. Rémi Danglahas beenappointed Chief Technology Officer and remains a member of the Board of Directors. Stilla technologies was founded in 2013 and is a global leader in […]
Partners Announce Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China […]
Mobile COVID-19 testing laboratories containing Oxford Nanopore’s LamPORE test are now being deployed in a pilot programme, to support testing efforts, including in remote locations. There are four mobile LamPORE units, currently located in Aberdeen, Telford, Brent and Newbury — where they are being used to support local testing services. This week the first unit […]
ITHACA, N.Y. — Rheonix Inc. today announced the appointment of Roy Proujansky, M.D., and Irving Nachamkin, DrPH, MPH, to its board of directors. “I’m honored to welcome Drs. Proujansky and Nachamkin to our board,” said Greg Galvin, Ph.D., founder and CEO of Rheonix. “They join Rheonix at an exciting time as we provide critical testing solutions to […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
